<DOC>
	<DOCNO>NCT02290834</DOCNO>
	<brief_summary>This research study evaluate effect chemotherapy cognition ( think ) brain people breast cancer .</brief_summary>
	<brief_title>Chemotherapy-induced Cognitive Brain Changes Older Adults With Breast Cancer</brief_title>
	<detailed_description>- This study do study effect chemotherapy ( cancer treatment ) brain cognition ( think ) . `` Chemo-brain '' term sometimes use refer effect chemotherapy brain cognition ( think ) . - This study do test `` chemo-brain '' old adult breast cancer treat chemotherapy , identify people likely affect . The investigator look think ability brain image chemotherapy see help identify people risk cognitive side effect treatment , good understand effect treatment brain structure function . - The investigator look participant either recently recently diagnose breast cancer participant healthy volunteer . - What involve study : - Memory Thinking Tests - Imaging : Either MRI/or MRI PET Scans</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<criteria>Breast cancer patient treat chemotherapy Group 1 ( experimental group ) Participants must meet follow criterion screen examination eligible participate behavioral +/ image component study New diagnosis histologically confirm invasive breast cancer Treatment plan include chemotherapy Female subject age ≥ 60 year . Life expectancy ≥ 1 year Karnofsky Performance Score ( KPS ) ≥ 80 Ability understand willingness sign write informed consent document . Nontreated breast cancer patient control Group 2 ( control group ) Participants must meet follow criterion screen examination eligible participate behavioral +/ image component study : New diagnosis histologically confirm invasive breast cancer Treatment plan include chemotherapy Age ≥ 60 year . Life expectancy ≥ 1 year Karnofsky Performance Score ( KPS ) ≥ 80 Ability understand willingness sign write informed consent document . Healthy control subject Group 3 ( control group ) Participants must meet follow criterion screen examination eligible participate behavioral +/ image component study : Age ≥ 60 year . Life expectancy ≥ 1 year Karnofsky Performance Score ( KPS ) ≥ 80 Ability understand willingness sign write informed consent document . Participants wellcontrolled vascular risk factor , treat hypertension , treat hyperlipidemia wellcontrolled Type II diabetes ( glucose level &lt; 250 ) may include . Serum Pregnancy Testing : STAT quantitative serum hCG pregnancy test woman childbearing potential . Imaging start unless test result return negative . Participants exhibit follow condition screen eligible admission study : Participants clinical radiographic evidence metastatic CNS disease Subjects MMSE score 24 Active history major psychiatric disorder schizophrenia , schizoaffective disorder , major affective disorder midlife , treatment ECT ( Mild depression well treat stable dose SSRI antidepressant may allow ) . Substance abuse within past 2 year Huntington 's disease , hydrocephalus seizure disorder In addition exclusion criterion , participant exhibit follow condition screen eligible admission image portion study : Participants contraindication MRI ( i.e. , implant metal include pacemaker , cerebral spinal fluid shunt , aneurysm clip , artificial heart valve , ear implant metal/foreign object eye history claustrophobia ) , injuries eye metal without Xray documentation metal remove</criteria>
	<gender>Female</gender>
	<minimum_age>60 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Chemotherapy relate cognitive impairment</keyword>
	<keyword>Chemo-brain</keyword>
</DOC>